Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Oct 7.
doi: 10.1515/cclm-2025-1030. Online ahead of print.

Towards harmonization of autoantibody detection in relation to paraneoplastic neurological syndromes (PNS): a European Survey on laboratory practices

Matthijs Oyaert  1 , Marco Schreurs  2 , David Goncalves  3 , Dina Patel  4 , Ravishankar Sargur  4 , Carol Stanley  4 , Monica Probst  5 , Marie-Agnès Durey  6 , Jan Damoiseaux  7 , Carolien Bonroy  1   8
Affiliations

Towards harmonization of autoantibody detection in relation to paraneoplastic neurological syndromes (PNS): a European Survey on laboratory practices

Matthijs Oyaert et al. Clin Chem Lab Med. .

Abstract

Objectives: Detection of paraneoplastic anti-neuronal antibodies (PNS autoantibodies) aids in diagnosing the particular syndrome and guides the search for an underlying tumor. To identify opportunities for harmonization that could enhance diagnostic value, we assessed variability in autoimmune serological testing for PNS across laboratories.

Methods: The European Autoimmunity Standardisation Initiative (EASI) developed a questionnaire addressing testing methods, digital tools, interpretation, clinical context, and quality assurance. This was distributed through two external quality assessment (EQA) providers (UK NEQAS and IfQ Lübeck) to clinical labs routinely performing PNS autoantibody assays.

Results: Among 139 responding laboratories, 78 % perform both cerebellum indirect immunofluorescence (IIF) and line/dot blot assays on serum and cerebrospinal fluid (76 %). Alignment on sample dilution (61 %) and conjugate type (70 %) is variable. Differences in antigen composition and reporting strategies contribute to variability in line/dot blot testing. Digitization is widespread for line/dot blot data (87 %) but limited for cerebellum IIF (31 %). About 53 % use testing algorithms that vary by sample type and requested antibodies. Internal quality control is performed by 89 % (IIF) and 48 % (line/dot blot), mainly using commercial controls. Nearly half (43 %) participate in multiple EQA programs; 46 % (IIF) and 42 % (line/dot blot) have ISO15189 certification, with 20 % planning certification. Positivity rates are low (<6 % in 73 % of labs), indicating low pre-test probability. While only 46 % restrict testing by discipline, most labs access clinical context (84 %) and interact with clinicians (63 %).

Conclusions: Considerable variability exists in PNS autoantibody assay execution, reporting, and quality control. Introducing lab-specific recommendations may harmonize practices and improve diagnostic quality.

Keywords: harmonization; immunology; paraneoplastic neurological syndromes.

PubMed Disclaimer

References

    1. Kannoth, S. Paraneoplastic neurologic syndrome: a practical approach. Ann Indian Acad Neurol 2012;15:6–12. https://doi.org/10.4103/0972-2327.93267 . - DOI
    1. Rosenfeld, MR, Dalmau, J. Paraneoplastic neurologic syndromes. Neurol Clin 2018;36:675–85. https://doi.org/10.1016/j.ncl.2018.04.015 . - DOI
    1. Loscalzo, J, Fauci, A, Kasper, D, Hauser, S, Longo, D, Jameson, JL. Harrison’s principles of internal medicine. In: Harrison’s Principles of Internal Medicine, 21e [Internet] , 21th ed.. New York, NY: McGraw-Hill Education; 2022. [geciteerd 6 augustus 2025].
    1. Tampoia, M, Zucano, A, Antico, A, Giometto, B, Bonaguri, C, Alessio, MG, et al.. Diagnostic accuracy of different immunological methods for the detection of antineuronal antibodies in paraneoplastic neurological syndromes. Immunol Invest 2010;39:186–95. https://doi.org/10.3109/08820130903513431 . - DOI
    1. Antoine, JC, Cinotti, L, Tilikete, C, Bouhour, F, Camdessanché, JP, Confavreux, C, et al.. [18F]fluorodeoxyglucose positron emission tomography in the diagnosis of cancer in patients with paraneoplastic neurological syndrome and anti-Hu antibodies. Ann Neurol 2000;48:105–8. https://doi.org/10.1002/1531-8249(200007)48:1<105::aid-ana16>3.0.c... .

LinkOut - more resources